Amicus Therapeutics (DE:AM6)

Amicus Financial Statements


Amicus Financial Overview

Amicus's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Amicus is scheduled to report earnings on February 23, 2023, and the estimated EPS forecast is €-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 81.69M$ 80.73M$ 78.72M$ 82.15M$ 79.55M
Gross Profit$ 68.25M$ 72.53M$ 71.13M$ 74.30M$ 67.85M
EBIT$ -19.64M$ -52.99M$ -73.30M$ -72.13M$ -42.31M
EBITDA$ -18.36M$ -51.66M$ -71.89M$ -70.61M$ -40.79M
Net Income Common Stockholders$ -33.29M$ -62.16M$ -85.26M$ -83.28M$ -50.29M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 354.70M$ 386.84M$ 411.19M$ 482.50M$ 556.96M
Total Assets$ 759.53M$ 800.59M$ 826.94M$ 905.14M$ 956.67M
Total Debt$ 450.87M$ 451.04M$ 447.71M$ 440.13M$ 439.39M
Net Debt$ 96.17M$ 64.20M$ 36.51M$ -42.37M$ -117.57M
Total Liabilities$ 626.96M$ 627.16M$ 588.32M$ 597.77M$ 580.05M
Stockholders Equity$ 132.56M$ 173.43M$ 238.62M$ 307.37M$ 376.63M
Cash Flow
Free Cash Flow$ -11.49M$ -16.22M$ -59.19M$ -72.27M$ -24.59M
Operating Cash Flow$ -11.63M$ -15.86M$ -58.31M$ -70.51M$ -23.70M
Investing Cash Flow$ 74.52M$ 26.29M$ 58.21M$ -68.09M$ 34.57M
Financing Cash Flow$ -559.00K$ 693.00K$ -8.15M$ -104.00K$ 201.11M
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis